You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 638 COMMANDER-001: a phase 1/2, first-in-human, multicenter, open label study of SQZ-eAPC-HPV as monotherapy and with pembrolizumab in patients with HPV16+ recurrent, locally advanced, or metastatic solid tumors (trial in progress)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
638 COMMANDER-001: a phase 1/2, first-in-human, multicenter, open label study of SQZ-eAPC-HPV as monotherapy and with pembrolizumab in patients with HPV16+ recurrent, locally advanced, or metastatic solid tumors (trial in progress)
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to March 2024

AbstractFullPdf
Nov 2022352019
Dec 202292010
Jan 202384010
Feb 20234609
Mar 20234605
Apr 20233500
May 20232201
Jun 20232601
Jul 20232606
Aug 20234704
Sep 20232204
Oct 20233903
Nov 20235203
Dec 20238606
Jan 20243201
Feb 202422044
Mar 20241603
Total10450129